Ergomed provides complete Phase I-IV clinical development and trial management services, offering comprehensive solutions tailored to our clients’ unique requirements.
• Global full service CRO • 1000+ highly qualified professionals •Therapeutic specialization in oncology • Strong expertise in rare disease trials •Robust clinical safety system • Choice of leading drug safety databases
• Actively supporting potential treatments for patients with COVID-19.
Contact us today to discuss how we can support you.